Dextera Surgical stock price, revenue, and financials

Dextera Surgical market cap is $7.5 m, and annual revenue was $2.53 b in FY 2016

$7.5 M

Mkt cap, 31-Oct-2017

$2.5 B

Dextera Surgical Revenue FY, 2016
Dextera Surgical Gross profit (FY, 2016)-1.4 B
Dextera Surgical Gross profit margin (FY, 2016), %(54.1%)
Dextera Surgical Net income (FY, 2016)-16 M
Dextera Surgical EBIT (FY, 2016)-15.6 B
Dextera Surgical Cash, 30-Jun-20163.6 M

Dextera Surgical Income Statement

Annual

USDFY, 2016

Revenue

2.5b

Cost of goods sold

3.9b

Gross profit

(1.4b)

Gross profit Margin, %

(54%)

R&D expense

6.3b

General and administrative expense

9.4b

Operating expense total

15.7b

EBIT

(15.6b)

EBIT margin, %

(615%)

Interest expense

497.0m

Interest income

62.0m

Net Income

(16.0m)

Dextera Surgical Balance Sheet

Annual

USDFY, 2016

Cash

3.6m

Accounts Receivable

313.0k

Inventories

1.1m

Current Assets

14.4m

PP&E

1.2m

Total Assets

15.7m

Accounts Payable

766.0k

Current Liabilities

2.6m

Additional Paid-in Capital

196.4m

Retained Earnings

(205.7m)

Total Equity

7.3m

Financial Leverage

2.2 x

Dextera Surgical Cash Flow

Annual

USDFY, 2016

Net Income

(16.0m)

Accounts Receivable

111.0k

Inventories

328.0k

Cash From Operating Activities

(12.1m)

Purchases of PP&E

(250.0k)

Cash From Investing Activities

7.4m

Interest Paid

200.0k

Dextera Surgical Ratios

USDFY, 2016

Financial Leverage

2.2 x